[1]
Levent YENİAY, “Prognostic value of somatostatin receptor-2 positivity in gastroenteropancreatic neuroendocrine tumors in reference to known prognostic factors”, Turkish Journal of Gastroenterology, vol. 23, no. 6, pp. 736–740, Jul. 2019.